$Bob's and Jbem's Bitchin' Bios

[BioSpecialist]

SNOA (MC $19 M) ( $12.6 M) Book Value $4.32 / Annual Revenue on track to hit $16 Million and only 4.3 Million Shares Outstanding this stock is a MASSIVE opportunity .Please do your own dd and realize the mega potential guys .GL


Sonoma Pharma (Nasdaq: SNOA)

Marketcap: 19.6 Million
Cash: $12.6 Million
Price: $4.55

Book Value: $4.32
Annual Revenue on track to hit $16 Million

Shares Out : 4.3 Million

Stonegate Capital Partners Updates Coverage on Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) ..October 18, 2017
http://pr.report/78EFCjq0

As of 6/30/17, the Company reported $3.8M in total revenue for Q1 FY18, with product revenues up 49% year-over-year driven by growth in US dermatology and acute care markets and in products sold to new owner of Latin American assets, and with approximately $12.6M in cash on hand and minimal debt. On an EV/R basis, Sonoma currently trades at 0.2x vs. the median of its peers at 34.5x based on FY18 estimates. In addition, companies in the dermatology space have been acquired at a median EV/R multiple of 3.6x. See full report for additional details.


Sonoma Pharmaceuticals Announces U.S. Commercialization of Loyon® for Relief of Scaling, Burning and Itching Associated with Various Dermatoses Including Seborrhea and Seborrheic Dermatitis
https://finance.yahoo.com/news/sonoma-pharmaceuticals-announces-u-commercialization-080500194.html